![Jon Stonehouse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon Stonehouse
Direktor/Vorstandsmitglied bei
BIOCRYST PHARMACEUTICALS, INC.
Vermögen: 14 Mio $ am 30.06.2026
Profil
Jon P.
Stonehouse is currently Director at The North Carolina Museum of Life & Science, Inc. and Director at BioCryst Pharmaceuticals, Inc. since 2025.
Former positions include Chairman at Bellicum Pharmaceuticals, Inc. from 2022 to 2024, Director-Marketing & Sales at AstraZeneca PLC, Director at Precision BioSciences, Inc., Director-Marketing & Sales at Astra Merck, Inc., Director at Metsera, Inc. in 2025, Manager-District Sales at Merck & Co., Inc., SVP-Corporate Development & VP-Global Licensing at Merck KGaA from 2002 to 2006, and Vice President-Licensing & Business Development at EMD Pharmaceuticals, Inc. Education includes undergraduate studies at the University of Minnesota.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.06.2026 | 1’419’775 ( 0.56% ) | 14 Mio $ | 30.06.2026 |
Aktive Positionen von Jon Stonehouse
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2007 |
The North Carolina Museum of Life & Science, Inc.
 The North Carolina Museum of Life & Science, Inc. Other Consumer ServicesConsumer Services Operates museums and exhibitions | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jon Stonehouse
| Unternehmen | Position | Ende |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Vorsitzender | 23.02.2024 |
| MERCK KGAA | Corporate Officer/Principal | 01.12.2006 |
| PRECISION BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | - |
| MERCK & CO., INC. | Vertrieb & Marketing | - |
Ausbildung von Jon Stonehouse
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Sells pharmaceuticals products | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
The North Carolina Museum of Life & Science, Inc.
The North Carolina Museum of Life & Science, Inc. Other Consumer ServicesConsumer Services Operates museums and exhibitions | Consumer Services |
